62 related articles for article (PubMed ID: 2486607)
1. [Establishment of Characterization of Seki cell line from an Ewing's sarcoma].
Nojima T; Inoue K; Nagashima K; Abe S; Sasaki M; Yamawaki S
Hum Cell; 1989 Jun; 2(2):192-3. PubMed ID: 2486607
[No Abstract] [Full Text] [Related]
2. The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit.
Landuzzi L; De Giovanni C; Nicoletti G; Rossi I; Ricci C; Astolfi A; Scopece L; Scotlandi K; Serra M; Bagnara GP; Nanni P; Lollini PL
Am J Pathol; 2000 Dec; 157(6):2123-31. PubMed ID: 11106584
[TBL] [Abstract][Full Text] [Related]
3. Congenital extraskeletal Ewing's sarcoma of chest wall--a rare case report.
Atla B; Prasad BS; Sri KS; Vandana G
Indian J Pathol Microbiol; 2011; 54(4):803-5. PubMed ID: 22234116
[TBL] [Abstract][Full Text] [Related]
4. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
[TBL] [Abstract][Full Text] [Related]
5. Ewing's sarcoma. Characterization in established cultures and evidence of its histogenesis.
Dickman PS; Liotta LA; Triche TJ
Lab Invest; 1982 Oct; 47(4):375-82. PubMed ID: 6750238
[TBL] [Abstract][Full Text] [Related]
6. Nude mouse lung metastases models of osteosarcoma and Ewing's sarcoma for evaluating new therapeutic strategies.
Jia SF; Zhou RR; Kleinerman ES
Methods Mol Med; 2003; 74():495-505. PubMed ID: 12415717
[No Abstract] [Full Text] [Related]
7. Bone induction by Ewing's sarcoma. Transplantation into athymic nude mice.
Bauer FC; Mirra JM; Urist MR
Arch Pathol Lab Med; 1981 Jun; 105(6):322-4. PubMed ID: 6894528
[TBL] [Abstract][Full Text] [Related]
8. Vasculogenesis driven by bone marrow-derived cells is essential for growth of Ewing's sarcomas.
Yu L; Su B; Hollomon M; Deng Y; Facchinetti V; Kleinerman ES
Cancer Res; 2010 Feb; 70(4):1334-43. PubMed ID: 20124484
[TBL] [Abstract][Full Text] [Related]
9. Secretogranin II expression in Ewing's sarcomas and primitive neuroectodermal tumors.
Pagani A; Fischer-Colbrie R; Sanfilippo B; Winkler H; Cerrato M; Bussolati G
Diagn Mol Pathol; 1992 Sep; 1(3):165-72. PubMed ID: 1342962
[TBL] [Abstract][Full Text] [Related]
10. [Stem cells and connective-tissue tumors: Ewing's sarcoma].
Tirode F; Delattre O
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S33-4. PubMed ID: 18984293
[No Abstract] [Full Text] [Related]
11. Establishment and characterization of a primitive neuroectodermal tumor of bone continuous cell line (LAP-35).
Bagnara GP; Serra M; Giovannini M; Badiali M; Stella M; Montaldi A; Granchi D; Paolucci P; Rocchi P; Pession A
Int J Cell Cloning; 1990 Nov; 8(6):409-24. PubMed ID: 2177080
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy.
Zhou Z; Bolontrade MF; Reddy K; Duan X; Guan H; Yu L; Hicklin DJ; Kleinerman ES
Clin Cancer Res; 2007 Aug; 13(16):4867-73. PubMed ID: 17699866
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of a new Ewing's sarcoma cell line.
Kodama K; Doi O; Higashiyama M; Mori Y; Horai T; Tateishi R; Aoki Y; Misawa S
Cancer Genet Cytogenet; 1991 Nov; 57(1):19-30. PubMed ID: 1756482
[TBL] [Abstract][Full Text] [Related]
14. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
15. Survival outcomes of pediatric osteosarcoma and Ewing's sarcoma: a comparison of surgery type within the SEER database, 1988-2007.
Schrager J; Patzer RE; Mink PJ; Ward KC; Goodman M
J Registry Manag; 2011; 38(3):153-61. PubMed ID: 22223058
[TBL] [Abstract][Full Text] [Related]
16. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
[TBL] [Abstract][Full Text] [Related]
17. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.
Girnita L; Girnita A; Wang M; Meis-Kindblom JM; Kindblom LG; Larsson O
Oncogene; 2000 Aug; 19(37):4298-301. PubMed ID: 10980604
[TBL] [Abstract][Full Text] [Related]
18. STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors.
Grunewald TG; Diebold I; Esposito I; Plehm S; Hauer K; Thiel U; da Silva-Buttkus P; Neff F; Unland R; Müller-Tidow C; Zobywalski C; Lohrig K; Lewandrowski U; Sickmann A; Prazeres da Costa O; Görlach A; Cossarizza A; Butt E; Richter GH; Burdach S
Mol Cancer Res; 2012 Jan; 10(1):52-65. PubMed ID: 22080479
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
Kubo T; Shimose S; Matsuo T; Tanaka K; Yasunaga Y; Sakai A; Ochi M
J Orthop Res; 2006 Jun; 24(6):1138-44. PubMed ID: 16705696
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a human endocrine tissue and tumor-associated Ewing's sarcoma antigen.
Hamilton G; Fellinger EJ; Schratter I; Fritsch A
Cancer Res; 1988 Nov; 48(21):6127-31. PubMed ID: 2844401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
